HK1055117A1 - 8,8A-dihydro-indenoÄ11,2-dÜthiazole derivatives, amethod for their production and their use as medi caments. - Google Patents

8,8A-dihydro-indenoÄ11,2-dÜthiazole derivatives, amethod for their production and their use as medi caments.

Info

Publication number
HK1055117A1
HK1055117A1 HK03107412A HK03107412A HK1055117A1 HK 1055117 A1 HK1055117 A1 HK 1055117A1 HK 03107412 A HK03107412 A HK 03107412A HK 03107412 A HK03107412 A HK 03107412A HK 1055117 A1 HK1055117 A1 HK 1055117A1
Authority
HK
Hong Kong
Prior art keywords
derivatives
indenoä11
düthiazole
amethod
dihydro
Prior art date
Application number
HK03107412A
Other languages
English (en)
Inventor
Gerhard Jaehne
Matthias Gosseel
Martin Bickel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of HK1055117A1 publication Critical patent/HK1055117A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fuses (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK03107412A 2000-02-23 2003-10-15 8,8A-dihydro-indenoÄ11,2-dÜthiazole derivatives, amethod for their production and their use as medi caments. HK1055117A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008275 2000-02-23
PCT/EP2001/001499 WO2001062746A1 (de) 2000-02-23 2001-02-12 8,8a-DIHYDRO-INDENO[1,2-d]THIAZOL-DERIVATE, DIE IN 8a-STELLUNG SUBSTITUIERT SIND; VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL Z.B. ALS ANOREKTIKA

Publications (1)

Publication Number Publication Date
HK1055117A1 true HK1055117A1 (en) 2003-12-24

Family

ID=7631989

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03107412A HK1055117A1 (en) 2000-02-23 2003-10-15 8,8A-dihydro-indenoÄ11,2-dÜthiazole derivatives, amethod for their production and their use as medi caments.

Country Status (27)

Country Link
US (1) US6403624B1 (xx)
EP (1) EP1259498B1 (xx)
JP (1) JP4898052B2 (xx)
KR (1) KR20020079891A (xx)
CN (1) CN1195747C (xx)
AT (1) ATE283265T1 (xx)
AU (1) AU781003B2 (xx)
BR (1) BR0108605A (xx)
CA (1) CA2400698A1 (xx)
CZ (1) CZ20022838A3 (xx)
DE (1) DE50104600D1 (xx)
EE (1) EE200200466A (xx)
ES (1) ES2231482T3 (xx)
HK (1) HK1055117A1 (xx)
HR (1) HRP20020688A2 (xx)
HU (1) HUP0300140A3 (xx)
IL (1) IL151327A0 (xx)
MX (1) MXPA02007021A (xx)
NO (1) NO20023978L (xx)
NZ (1) NZ520926A (xx)
PL (1) PL357547A1 (xx)
PT (1) PT1259498E (xx)
RU (1) RU2261860C2 (xx)
SK (1) SK12162002A3 (xx)
WO (1) WO2001062746A1 (xx)
YU (1) YU56302A (xx)
ZA (1) ZA200206487B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10142660A1 (de) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142659A1 (de) * 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
MX2011004258A (es) 2008-10-22 2011-06-01 Merck Sharp & Dohme Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
JP5557845B2 (ja) 2008-10-31 2014-07-23 メルク・シャープ・アンド・ドーム・コーポレーション 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
AU2011218830B2 (en) 2010-02-25 2014-07-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP3243385B1 (en) 2011-02-25 2021-01-13 Merck Sharp & Dohme Corp. Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
AU2013296470B2 (en) 2012-08-02 2016-03-17 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
EP2958562A4 (en) 2013-02-22 2016-08-10 Merck Sharp & Dohme BICYCLIC ANTIDIABETIC COMPOUNDS
US9650375B2 (en) 2013-03-14 2017-05-16 Merck Sharp & Dohme Corp. Indole derivatives useful as anti-diabetic agents
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
EP3551176A4 (en) 2016-12-06 2020-06-24 Merck Sharp & Dohme Corp. ANTIDIABETIC HETEROCYCLIC COMPOUNDS
US10968232B2 (en) 2016-12-20 2021-04-06 Merck Sharp & Dohme Corp. Antidiabetic spirochroman compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640358A1 (de) 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
JP2003528825A (ja) 2003-09-30
AU781003B2 (en) 2005-04-28
DE50104600D1 (de) 2004-12-30
US6403624B1 (en) 2002-06-11
HUP0300140A3 (en) 2004-10-28
NZ520926A (en) 2004-08-27
PL357547A1 (en) 2004-07-26
HRP20020688A2 (en) 2004-12-31
NO20023978D0 (no) 2002-08-21
SK12162002A3 (sk) 2003-02-04
WO2001062746A1 (de) 2001-08-30
EP1259498B1 (de) 2004-11-24
ES2231482T3 (es) 2005-05-16
JP4898052B2 (ja) 2012-03-14
CZ20022838A3 (cs) 2002-11-13
CA2400698A1 (en) 2001-08-30
CN1195747C (zh) 2005-04-06
CN1423640A (zh) 2003-06-11
US20020058658A1 (en) 2002-05-16
KR20020079891A (ko) 2002-10-19
IL151327A0 (en) 2003-04-10
MXPA02007021A (es) 2003-03-27
ZA200206487B (en) 2003-10-16
RU2261860C2 (ru) 2005-10-10
RU2002125460A (ru) 2004-01-10
ATE283265T1 (de) 2004-12-15
EE200200466A (et) 2003-12-15
BR0108605A (pt) 2002-11-19
AU5615301A (en) 2001-09-03
NO20023978L (no) 2002-10-18
YU56302A (sh) 2005-11-28
HUP0300140A2 (en) 2003-05-28
EP1259498A1 (de) 2002-11-27
PT1259498E (pt) 2005-02-28

Similar Documents

Publication Publication Date Title
HK1055117A1 (en) 8,8A-dihydro-indenoÄ11,2-dÜthiazole derivatives, amethod for their production and their use as medi caments.
TNSN05194A1 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
MY145133A (en) Aryl-substituted polycyclic amines, process for their preparation and their use as medicaments
TNSN04199A1 (en) Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
YU91002A (sh) Derivati acilfenil-karbamida, postupak za njihovu proizvodnju i njihova primena kao leka
MXPA04001307A (es) Compuestos biciclicos aromaticos sustituidos con aminoalquilo, metodo para la produccion de los mismos y su uso como farmacos.
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
PL1682528T3 (pl) Pochodne benzo[b][1,4]dioksepiny
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
IL165558A0 (en) N-benzoylureidocinnamate derivatives method for production and use thereof
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
HK1043117A1 (en) Polycyclic 2-amino-thiazole systems, method for the production thereof and medicament containing said compounds
RS88704A (xx) Derivati acil-3-karboksifenil- karbamida, postupak za njihovu proizvodnju i njihova primena
TNSN02096A1 (en) Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
TW200504051A (en) Novel acridine derivatives and their use as medicaments
HK1042300B (zh) 多環的噻唑體系和它們作為減食慾劑的用途
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
MXPA05008331A (es) Derivados de 3-(benzoilureido)-tiofeno sustituido, metodo para su produccion y uso de los mismos.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
HK1042299A1 (en) Polycyclic thiazole-2-ylides amines, method for the production thereof and their utilization as medicaments.
MXPA03003466A (es) Derivados de piranosido.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090212